Company: INMB
Filing Date: 2025-06-30
Form Type: 424B5
Source: 0001213900-25-059298
Chunk: 10

Company: Inmune Bio, Inc.
Filing Date: 2025-06-30
Form: 424B5
Chunk 10
---
representations, warranties and covenants made in the agreement.

Further,
our rights to current or future in-licensed patents and patent applications may be dependent, in part, on inter-institutional or other
operating agreements between the joint owners of such in-licensed patents and patent applications. If one or more of such joint owners
breaches such inter-institutional or operating agreements, our rights to such in-licensed patents and patent applications may be adversely
affected. Any of these events could have a material adverse effect on our competitive position, business, financial conditions, results
of operations, and prospects.

Intellectual property discovered through government funded programs may be subject to federal regulations such as “march-in” rights, certain reporting requirements and a preference for U.S.-based companies. Compliance with such regulations may limit our exclusive rights and limit our ability to contract with non-U.S. manufacturers.

Certain
in-licensed patents (i.e. those from the University of Pittsburgh) were supported through the use of U.S. government funding. Pursuant
to the Bayh-Dole Act of 1980, the U.S. government has certain rights in inventions developed with government funding. These U.S. government
rights include a non-exclusive, non-transferable, irrevocable worldwide license to use inventions for any governmental purpose. In addition,
the U.S. government has the right, under certain limited circumstances, to require us to grant exclusive, partially exclusive, or non-exclusive
licenses to any of these inventions to a third party if it determines that: (1) adequate steps have not been taken to commercialize the
invention; (2) government action is necessary to meet public health or safety needs; or (3) government action is necessary to meet requirements
for public use under federal regulations (also referred to as march-in rights). If the U.S. government exercised its march-in rights in
our current or future intellectual property rights that are generated through the use of U.S. government funding or grants, we could be
forced to license or sublicense intellectual property developed by us or that we license on terms unfavorable to us, and there can be
no assurance that we would receive compensation from the U.S. government for the exercise of such rights. The U.S. government also has
the right to take title to these inventions if the grant recipient fails to disclose the invention to the government or fails to file
an application to register the intellectual property within specified time limits. Intellectual property generated under a government